| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |